Table 3.
Concordance of data sources on any DMT use in MS patients.a
| Imputation | Patient-reported MS medication | MS medication in claims (5 years) | Agreementb | ||||
| Any DMT | No DMT | Total | Overall | PPA | NPA | ||
|
|
Overall any DMT | 195 | 156 | 351 | 58.7% | 97.0% | 18.3% |
| No | Overall no DMT | 6 | 35 | 41 |
|
|
|
|
|
Total | 201 | 191 | 392 |
|
|
|
| No | Any DMT (5 years) | 111 | 77 | 188 | 57.4% | 55.2% | 59.7% |
| No DMT (5 years) | 90 | 114 | 204 |
|
|
|
|
| Total | 201 | 191 | 392 |
|
|
|
|
| Yes | Any DMT (5 years) | 162 | 122 | 284 | 58.9% | 80.6% | 36.1% |
| No DMT (5 years) | 39 | 69 | 108 |
|
|
|
|
| Total | 201 | 191 | 392 |
|
|
|
|
aDMT use categories in this table reflect claims or patient reported; if no dates available then included under “no” for no imputation; missing dates for DMT use imputed based on date of medication entry to evaluate use within 5 years in section marked “yes.”
bPPA and NPA calculations use claims as reference.